Chinese Journal of Mycology 2015, Vol. 10 Issue (1): 44-48.
Previous Articles Next Articles
Received:2015-01-07
Online:2015-02-28
Published:2015-02-28
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/
http://cjmycology.smmu.edu.cn:81/Jweb_zgzj/EN/Y2015/V10/I1/44
| [1] Park BJ,Wannemuehler KA,Marston BJ,et al.Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J].AIDS,2009,23(4):525-530. [2] Husain S,Wagener MM,Singh N.Cryptococcus neoformans infection in organ transplant recipients:variables influencing clinical characteristics and outcome[J].Emerg Infect Dis,2001,7(3):375-381. [3] Oladele RO,Denning DW.Burden of serious fungal infection in Nigeria[J].West Afr J Med,2014,33(2):107-114. [4] Shahapur PR,Bidri RC.Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India[J].J Nat Sci Biol Med,2014,5(2):392-396. [5] Boulware DR,Rolfes MA,Rajasingham R,et al.Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast[J].Emerg Infect Dis,2014,20(1):45-53. [6] Lee SC,Casadevall A,Dickson DW.Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis[J].Am J Pathol,1996,148(4):1267-1274. [7] Lee SC,Dickson DW,Casadevall A.Pathology of cryptococcal meningoencephalitis:analysis of 27 patients with pathogenetic implications[J].Hum Pathol,1996,27(8):839-847. [8] Binnicker MJ,Jespersen DJ,Bestrom JE,Rollins LO.Comparison of four assays for the detection of cryptococcal antigen[J].Clin Vaccine Immunol,2012,19(12):1988-1990. [9] Lindsley MD,Mekha N,Baggett HC,et al.Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis[J].Clin Infect Dis,2011,53(4):321-325. [10] Jarvis JN,Percival A,Bauman S,et al.Evaluation of a novel point-of-care cryptococcal antigen test on serum,plasma,and urine from patients with HIV-associated cryptococcal meningitis[J].Clin Infect Dis,2011,53(10):1019-1023. [11] Gates-Hollingsworth MA,Kozel TR.Serotype sensitivity of a lateral flow immunoassay for cryptococcal antigen[J].Clin Vaccine Immunol,2013,20(4):634-635. [12] Hansen J,Slechta ES,Gates-Hollingsworth MA,et al.Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid[J].Clin Vaccine Immunol,2013,20(1):52-55. [13] IMMY Cryptococcal Antigen Lateral Flow Assay[EB/OL].[2012-7-29].http://www.immy.com/products/cryptococcal-antigen-lateral-flow-assay-lfa/. [14] Kwizera R,Nguna J,Kiragga A,et al.Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100[J].PLoS One,2014,9(7):e103156. [15] 王劲,张雪林,张三泉,等.隐球菌性脑膜脑炎的CT、MRI影像表现及其诊断意义[J].中国医学影像学杂志,2003,11(3):194-196. [16] Bicanic T,Wood R,Meintjes G,et al.High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients:a randomized trial[J].Clin Infect Dis,2008,47(1):123-130. [17] Hamill RJ,Sobel JD,El-Sadr W,et al.Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis:a randomized,double-blind clinical trial of efficacy and safety[J].Clin Infect Dis,2010,51(2):225-232. [18] Brouwer AE,Rajanuwong A,Chierakul W,et al.Combination antifungal therapies for HIV-associated cryptococcal meningitis:a randomised trial[J].Lancet,2004,363(9423):1764-1767. [19] Pappas PG,Chetchotisakd P,Larsen RA,et al.A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis[J].Clin Infect Dis,2009,48(12):1775-1783. [20] Loyse A,Wilson D,Meintjes G,et al.Comparison of the early fungicidal activity of high-dose fluconazole,voriconazole,and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis[J].Clin Infect Dis,2012,54(1):121-128. [21] Day JN,Chau TT,Lalloo DG.Combination antifungal therapy for cryptococcal meningitis[J].N Engl J Med,2013,368(26):2522-2523. [22] Bozzette SA,Larsen RA,Chiu J,et al.A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome.California Collaborative Treatment Group[J].N Engl J Med,1991,324(9):580-584. [23] Kirk O,Reiss P,Uberti-Foppa C,et al.Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy[J].Ann Intern Med,2002,137(4):239-250. [24] Vibhagool A,Sungkanuparph S,Mootsikapun P,et al.Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy:a prospective,multicenter,randomized study[J].Clin Infect Dis,2003,36(10):1329-1331. [25] Makadzange AT,McHugh G.New approaches to the diagnosis and treatment of cryptococcal meningitis[J].Semin Neurol,2014,34(1):47-60. [26] Zolopa A,Andersen J,Powderly W,et al.Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections:a multicenter randomized strategy trial[J].PLoS One,2009,4(5):e5575. [27] Abdool KSS,Naidoo K,Grobler A,et al.Timing of initiation of antiretroviral drugs during tuberculosis therapy[J].N Engl J Med,2010,362(8):697-706. [28] Makadzange AT,Ndhlovu CE,Takarinda K,et al.Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa[J].Clin Infect Dis,2010,50(11):1532-1538. [29] Boulware DB,Meya DB,Muzoora C,et al.ART Initiation within the First 2 Weeks of Cryptococcal Meningitis Is Associated with Higher Mortality:A Multisite Randomized Trial.In:20th Conference on Retroviruses and Opportunistic Infections.2013,March 3-6,2013;Atlanta,GA.Oral abstract 144. [30] Bisson GP,Molefi M,Bellamy S,et al.Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis[J].Clin Infect Dis,2013,56(8):1165-1173. [31] Jarvis JN,Lawn SD,Vogt Met al.Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa[J].Clin Infect Dis,2009,48(7):856-862. [32] Jarvis JN,Harrison TS,Lawn SDet al.Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa[J].PLoS One,2013,8(7):e69288. [33] Hole CR,Wormley FL Jr.Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis:lessons learned from animal models[J].Front Microbiol,2012,3:291. [34] Netea MG,Brouwer AE,Hoogendoorn EH,et al.Two patients with cryptococcal meningitis and idiopathic CD4 lymphopenia:defective cytokine production and reversal by recombinant interferon- gamma therapy[J].Clin Infect Dis,2004,39(9):e83-87. [35] Jarvis JN,Meintjes G,Rebe K,et al.Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis:a randomized controlled trial[J].AIDS,2012,26(9):1105-1113. [36] Pappas PG.Editorial Commentary:An expanded role for therapeutic lumbar punctures in newly diagnosed AIDS-associated cryptococcal meningitis[J].Clin Infect Dis,2014,59(11):1615-1617. [37] Rolfes MA,Hullsiek KH,Rhein J,et al.The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis[J].Clin Infect Dis,2014,59(11):1607-1614. [38] Wang H,Ling C,Chen C,et al.Evaluation of ventriculoperitoneal shunt in the treatment of intracranial hypertension in the patients with cryptococcal meningitis:a report of 12 cases[J].Clin Neurol Neurosurg,2014,124:156-160. [39] 黄欣,温海,姚志荣,等.颅内接种热灭活隐球菌对小鼠隐球菌脑膜脑炎作用的研究[J].中华皮肤科杂志,2003,36(8):457-460. [40] Barluzzi R,Brozzetti A,Mariucci G,et al.Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent,non melanogenic Cryptococcus neoformans strain[J].J Neuroimmunol,2000,109(2):75-86. [41] Devi SJ,Schneerson R,Egan W,et al.Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines:synthesis,characterization,and immunogenicity[J].Infect Immun,1991,59(10):3700-3707. |
| [1] | . [J]. Chinese Journal of Mycology, 2020, 15(6): 378-380. |
| [2] | HUANG Jin-bao, LAN Chang-qing, WEN Heng, LIN Qing-hua. Cryptococcal infection of the ribs mimicking malignant tumor: two cases report and literature review [J]. Chinese Journal of Mycology, 2020, 15(5): 278-282. |
| [3] | TAO Peng-fei, YANG Xin-ping, LI Zheng-lun, ZHOU Qi-wen, MIN Hai-yan, QIAN Qing-jin. Clinical features and treatment outcome of 30 cases of AIDS complicated with invasive cryptococcosis [J]. Chinese Journal of Mycology, 2020, 15(3): 150-153. |
| [4] | WANG Li-lin, LI Ai-xin, YANG Xue, Wang Wen, Wu Hao. Clinical analysis for 67 AIDS patients with cryptococcal meningitis [J]. Chinese Journal of Mycology, 2019, 14(6): 342-345. |
| [5] | HE Yuan-hong, TAN qing, YANG Tong-tong, HE Sheng-hua, WANG Yin, ZHOU Rui-feng, CAI Lin. Efficacy and safety of amphotericin B in 124 AIDS-associated cryptococcal meningitis patients [J]. Chinese Journal of Mycology, 2019, 14(6): 346-350. |
| [6] | LU Yan-qiu, WU Yu-shan, QIU Dan, CHEN Yao-kai. Retrospective analysis of 149 cases of cryptococcal meningitis with AIDS [J]. Chinese Journal of Mycology, 2019, 14(4): 204-209. |
| [7] | . [J]. Chinese Journal of Mycology, 2019, 14(4): 232-234. |
| [8] | WANG Guang-yu, CHEN Min, HONG Nan, WANG Sheng-qi, LIAO Wan-qing, YANG Ying. Study on the diagnosis of cryptococcal meningoencephalitis by molecular biological techniques [J]. Chinese Journal of Mycology, 2019, 14(2): 95-98. |
| [9] | WANG Yan-ling, YANG Yu-heng, YU Nong, DENG Shu-wen. Clinical characteristics on 11 immunocompetent patients with pulmonary cryptococcosis and literature review [J]. Chinese Journal of Mycology, 2018, 13(3): 148-151,163. |
| [10] | XIE Jing, GE Ying, QIU Zhi-feng, ZHANG Kai-yu, LIU Zheng-yin, LI Tai-sheng. Immunophenotype of peripheral lymphocytes in HIV-negative patients with cryptococcal meningitis [J]. Chinese Journal of Mycology, 2017, 12(5): 262-267. |
| [11] | HUANG Huang, XIAN Ying, PAN Yue-jun, ZHANG Kou-xing. The proportions of Th1/Th2 and Relevant T lymphocytes in patients with cryptococcal meningitis and its clinical significance [J]. Chinese Journal of Mycology, 2017, 12(5): 268-273,267. |
| [12] | ZHU Bo-cheng, PAN-Bo, GE Guo-jun, GAO Quan, LOU Bo-yang, XU Zhi-jie, ZHU Xiao-feng. A patient with renal allograft failure and disseminated cryptococcosis:a case report [J]. Chinese Journal of Mycology, 2017, 12(5): 295-297. |
| [13] | ZHANG Li-yan, ZHANG Dong-lei, TAN Xiao-ming, XIE Hui-kang. Pulmonary cryptococcosis presenting as necrotizing granuloma:a clinicopathologic analysis of 28 cases [J]. Chinese Journal of Mycology, 2017, 12(4): 212-215. |
| [14] | CAI Ren-hui, WANG Ying. Analysis of prognosis and clinical characteristics in 22 patients with Cryptococcus neoformans meningitis [J]. Chinese Journal of Mycology, 2017, 12(4): 216-220. |
| [15] | LIU Jian-qing, SHI Hong, WU Guo-lan, CHEN Yu-yan. A case of disseminated cryptococcosis and literature review [J]. Chinese Journal of Mycology, 2017, 12(4): 225-227. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
